Brilakis Emmanouil S, Karmpaliotis Dimitri, Vo Minh N, Garcia Santiago, Michalis Lampros, Alaswad Khaldoon, Doshi Parag, Lombardi William L, Banerjee Subhash
VA North Texas Healthcare System, Dallas, TX, USA,
J Cardiovasc Transl Res. 2014 Jun;7(4):426-36. doi: 10.1007/s12265-014-9556-6. Epub 2014 Mar 15.
Chronic total occlusions (CTOs) have been called "the last frontier" of percutaneous coronary intervention (PCI) due to traditionally low success rates and high risk for restenosis and re-occlusion. Recent advances in equipment and crossing techniques have significantly increased CTO PCI success rates while maintaining low risk of complications. Specifically, the retrograde approach and controlled antegrade dissection and re-entry in conjunction with advanced guidewires and microcatheters have significantly improved procedural success rates. Moreover, the introduction of the "hybrid" approach has created a unified framework for operators to approach CTOs in a systematic and efficient fashion. Finally, drug-eluting stents, especially second generation, have improved long-term patency after CTO PCI.
慢性完全闭塞病变(CTO)一直被称为经皮冠状动脉介入治疗(PCI)的“最后前沿阵地”,因为传统上其成功率较低,且再狭窄和再闭塞风险较高。设备和穿刺技术的最新进展显著提高了CTO PCI的成功率,同时保持了较低的并发症风险。具体而言,逆行技术以及结合先进导丝和微导管的可控顺行内膜下血管成形术和再入技术显著提高了手术成功率。此外,“杂交”技术的引入为术者提供了一个统一的框架,使其能够以系统且高效的方式处理CTO病变。最后,药物洗脱支架,尤其是第二代药物洗脱支架,改善了CTO PCI术后的长期通畅率。